OCT 25, 2022 10:20 AM PDT

Increase in Cannabis and Hallucinogen Use in Young People

WRITTEN BY: Kerry Charron

Cannabis and hallucinogen use among young people has increased among individuals from 19 to 30 years old. The Monitoring the Future (MTF) study conducted by the National Institutes of Health showed a dramatic increase in cannabis and hallucinogens. The MTF is a survey of young people’s substance use behaviors and attitudes. Longitudinal follow-up tracking a subset of participants' drug use through adulthood. 

Survey responses were collected online from April 2021 through October 2021 and were self-reported. Participant reported data shows cannabis use increased from 34% in 2016 to 43% in 2021. Reports of hallucinogen use including LSD, MDMA, mescaline, peyote, and psilocybin also started to increase in 2020. 

Although alcohol remains the most used substance among young adults in the study, drinking has decreased in the past decade. Binge drinking (five or more drinks in a row in the past two weeks) dropped during the early stages of COVID-19 pandemic in 2020 and then rose again in 2021. 

Nicotine vaping increased significantly among young adults. It increased from 6% in 2017 to 16% in 2021. Both binge drinking and cannabis vaping significantly dipped in 2020 but then increased in 2021. Cigarette smoking by young adults and non-medical use of opioid medication has decreased overall in the past decade. 

This study provides critical insights into substance abuse behavior. According to Dr. Megan Patrick, Ph.D., research professor at the University of Michigan and principal investigator, "One of the best ways we can learn more about drug use and its impact on people is to observe which drugs are appearing, in which populations, for how long, and under which contexts. Monitoring the Future and similar large-scale surveys on a consistent sample population allow us to assess the effects of ‘natural experiments’ like the pandemic." Examining young people’s substance use behavior can inform policy and public health interventions.

Sources: Eureka News Alert, NIH

 

About the Author
BA and MA in English, MPS in Human Relations, and Ed.D. in Higher Education Administration
Kerry Charron writes about medical cannabis research. She has experience working in a Florida cultivation center and has participated in advocacy efforts for medical cannabis.
You May Also Like
OCT 06, 2022
Cannabis Sciences
Synthetic Cannabinoids and Their Effects
OCT 06, 2022
Synthetic Cannabinoids and Their Effects
What are synthetic cannabinoids and what do they do to you? Are they safe or effective?
OCT 14, 2022
Cannabis Sciences
Pilot Study Examines How Medicinal Cannabis Mitigates Children's Symptoms in Palliative Care
OCT 14, 2022
Pilot Study Examines How Medicinal Cannabis Mitigates Children's Symptoms in Palliative Care
A future pilot study conducted by the Murdoch Children’s Research Institute and funded by the Australian State Gov ...
OCT 17, 2022
Cannabis Sciences
Weed Breathalyzers Are Coming
OCT 17, 2022
Weed Breathalyzers Are Coming
Scientists have developed a prototype that can determine how much THC is in your system, and if you're too impaired to d ...
OCT 18, 2022
Cannabis Sciences
Study Finds Hemp Byproducts Are a Safe Food Source for Lambs
OCT 18, 2022
Study Finds Hemp Byproducts Are a Safe Food Source for Lambs
An Oregon State University research team found that hemp byproducts are a safe food source for lambs. The study was rece ...
DEC 01, 2022
Cannabis Sciences
The first medical marijuana research bill
DEC 01, 2022
The first medical marijuana research bill
The first medical marijuana research bill is coming. Here's the details, and what it could mean for the science communit ...
DEC 02, 2022
Cancer
No Evidence that Cannabis Relieves Symptoms in Advanced Cancer Patients
DEC 02, 2022
No Evidence that Cannabis Relieves Symptoms in Advanced Cancer Patients
Palliative care describes a class of healthcare intended to enhance patients' quality of life with severe, life-thre ...
Loading Comments...